Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)

Chiara Tramontano,João Pedro Martins,Luca De Stefano,Marianna Kemell,Alexandra Correia,Monica Terracciano,Nicola Borbone,Ilaria Rea,Hélder A. Santos
DOI: https://doi.org/10.1002/adhm.202370029
IF: 10
2023-01-01
Advanced Healthcare Materials
Abstract:Nanoparticle Drug Delivery The encapsulation of nanoparticles in hydroxypropyl methyl cellulose is key to treat colorectal cancer through oral administration. In article 2202672 by Ilaria Rea, Hélder A. Santos, and co‐workers, gelatin‐coated diatomite nanoparticles loaded with galunisertib are functionalized with an anti‐L1‐CAM antibody that targets metastatic colon cancer cells. These nanoparticles are then encapsulated in a gastro‐resistant matrix using microfluidics. When the nanoparticles interact with the targeted cells, the gastro‐resistant coating dissolves and galunisertib is released.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?